NAT-LENALIDOMIDE
NATCO PHARMA (CANADA) INC
Quick answers
Is there a shortage of NAT-LENALIDOMIDE in Canada?
No. There is no current shortage of NAT-LENALIDOMIDE 2.5MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
TEVA-LENALIDOMIDE
TEVA CANADA LIMITED
Other Products
REVLIMID
BRISTOL-MYERS SQUIBB CANADA
LENALIDOMIDE
NATCO PHARMA (CANADA) INC
SANDOZ LENALIDOMIDE
SANDOZ CANADA INCORPORATED
APO-LENALIDOMIDE
APOTEX INC
NAT-LENALIDOMIDE
NATCO PHARMA (CANADA) INC
DIN
02493837
Strength
2.5MG
Dosage Form
Capsule
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from NATCO PHARMA (CANADA) INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
250MG · DIN 02494132
1MG · DIN 02417855
2.5MG · DIN 02492814
5MG · DIN 02492822
100MG · DIN 02496895
25MG · DIN 02496887
62.5MG · DIN 02467984
125MG · DIN 02467992
20MG · DIN 02496488
10MG · DIN 02496461
40MG · DIN 02409038
20MG · DIN 02409011